Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.79 |
| ▸ | PRKCG | P05129 | 6/20 | 0.79 |
| ▸ | PRKCB | P05771 | 5/20 | 0.79 |
| ▸ | PRKCH | P24723 | 5/20 | 0.79 |
| ▸ | PRKCE | Q02156 | 5/20 | 0.79 |
| ▸ | PRKCQ | Q04759 | 5/20 | 0.79 |
| ▸ | PRKCD | Q05655 | 5/20 | 0.79 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.79 |
| ▸ | PRKCI | P41743 | 4/20 | 0.79 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.79 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.79 |
| ▸ | USP2 | O75604 | 2/20 | 0.79 |
| ▸ | TP53 | P04637 | 2/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 1/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26309656 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL2413670 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL31074956 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL26310034 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL18622646 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL18399979 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL15725680 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL18629158 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL3516162 | 1.00 | PRKCA (0.79) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Acetic Acid SCHEMBL10517222 | 0.98 | PRKCA (0.78) | PRKCAPRKCGPRKCBPRKCHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13829 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041660-A1 | Compositions And Methods for Treating Acute Respiratory Distress Syndrome (ARDS) And Inflammatory Disorders Caused by Corona Viruses and Other Respiratory Pathogens or Agents That Mediate Pulmonary Injury, Inflammation or Acute Respiratory Distress, And Related Compositions and Methods for Treating and Preventing Human SARS Coronavirus Infection, COVID-19 Disease and Related Symptoms | CHANG RICHARD L (US) | 2026-02-12 | — | — | US | claimed |
| US-12539289-B2 | Phorbol ester compositions and methods of use for treating or reducing the duration of cytopenia | BIOSUCCESS BIOTECH COMPANY, LIMITED (US) | 2026-02-03 | — | — | US | claimed |
| EP-2804601-B1 | PHORBOL ESTER compounds for use in the treatment of neoplastic diseases | BIOSUCCESS BIOTECH CO LTD (US) | 2025-04-02 | — | — | EP | claimed |
| US-20240261247-A1 | COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS | BIOSUCCESS BIOTECH CO., LTD. (US) | 2024-08-08 | — | — | US | claimed |
| WO-2024147865-A1 | COMPOSITIONS AND METHODS TO DETECT AND INHIBIT NUCLEAR INVASION OF CYTOPLASM OR MITOCHONDRIA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (US) | 2024-07-11 | — | — | WO | claimed |
| EP-4396225-A1 | METHOD OF TREATMENT | Nucleus Therapeutics Pty Ltd (AU) | 2024-07-10 | — | — | EP | claimed |
| CN-118234846-A | Differentiation of stem cell derived islets | 沃泰克斯药物股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118201958-A | Therapeutic method | 核子疗法股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2024121796-A1 | METHODS FOR GENERATING GENETICALLY MODIFIED CYTOKINE INDUCED KILLER (CIK) CELLS | FONDAZIONE MATILDE TETTAMANTI E MENOTTI DE MARCHI ONLUS (IT) | 2024-06-13 | — | — | WO | claimed |
| US-20240182565-A1 | CD33 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY | CELLECTIS (FR) | 2024-06-06 | — | — | US | claimed |
| US-5385915-A | Using an enzyme inhibitor | THE ROCKEFELLER UNIVERSITY (US) | 1995-01-31 | — | — | US | claimed |
| WO-1994016715-A1 | SELECTIVE CELL PROLIFERATION | HEMOSOL, INC. (CA) | 1994-08-04 | — | — | WO | claimed |
| EP-0553107-A1 | PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY | PROCYON PHARMACEUTICALS, INC. (US) | 1993-08-04 | — | — | EP | claimed |
| EP-0310622-B1 | ANTI-INFLAMMATORY COMPOSITIONS | ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) | 1992-04-15 | — | — | EP | claimed |
| WO-1992002484-A1 | PROTEIN KINASE C MODULATORS WITH ANTI-INFLAMMATORY AND ANTIVIRAL ACTIVITY | ALDER RESEARCH CENTER LIMITED PARTNERSHIP (US) | 1992-02-20 | — | — | WO | claimed |
| EP-0457295-A2 | Use of a modulator of protein phosphorylation in the treatment of amyloidosis associated with Alzheimer's disease | THE ROCKEFELLER UNIVERSITY (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0455271-A2 | Anti-inflammatory compositions | PROCYON PHARMACEUTICALS, INC. (US) | 1991-11-06 | — | — | EP | claimed |
| EP-0310622-A1 | ANTI-INFLAMMATORY COMPOSITIONS. | ALDER RES CENTER CORP (US) | 1989-04-12 | — | — | EP | claimed |
| US-4803163-A | GROWING HUMAN DIPLOID FIBROBLASTS CELLS IN A CULTURE MEDIUM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-02-07 | — | — | US | claimed |
| WO-1987007599-A2 | ANTI-INFLAMMATORY COMPOSITIONS | ALDER RESEARCH CENTER CORPORATION (US) | 1987-12-17 | — | — | WO | claimed |